Alpheus Medical Raises $52M for Innovative Brain Cancer Treatment

Alpheus Medical raises $52M for innovative brain cancer treatment

A Minnesota-based medical company has secured a substantial investment to further its groundbreaking approach to treating one of the deadliest forms of brain cancer.

Alpheus Medical Raises $52M in Series B Funding

Alpheus Medical, a Chanhassen, MN-based private, clinical-stage oncology company, raised $52M in Series B funding. The round was led by HealthQuest Capital and Samsara BioCapital with participation from existing investors OrbiMed, Action Potential Venture Capita, BrightEdge, the Brain Tumor Investment Fund, and Sontag Innovation Fund. The company intends to use the funds to support a Phase 2B randomized controlled trial (RCT) evaluating the effi…